Aker BioMarine AS/Nkr AKBM
07:00
08:50
10:40
12:30
14:20
1D1W1MYTD1Y5YMAX
About Aker BioMarine AS
Aker BioMarine AS is a biotechnology company focused on the sustainable harvesting, production, and distribution of krill-based products. Its core business operates within the marine biotechnology industry, emphasizing krill-derived ingredients for the health and nutrition sectors. The company's main products include krill oil for human consumption, utilized in dietary supplements, and krill meal used in feed for aquaculture. Headquartered in Oslo, Norway, Aker BioMarine maintains operations in the Southern Ocean where it conducts its krill harvesting activities. A unique aspect of its strategic positioning is its commitment to sustainability, which is underpinned by proprietary technology and practices designed to minimize environmental impact and ensure the responsible management of marine resources.
Ticker
Nkr AKBM
Sector
Primary listing
XOSL
Employees
258
Headquarters
Lysaker, Norway
Website
AKBM Metrics
BasicAdvanced
kr 9.4B
-
-kr 2.54
0.29
-
Price and volume
Market cap
kr 9.4B
Beta
0.29
52-week high
kr 118.00
52-week low
kr 43.65
Average daily volume
17K
Financial strength
Current ratio
2.57
Quick ratio
0.834
Long term debt to equity
110.702
Total debt to equity
126.616
Interest coverage (TTM)
0.81%
Profitability
EBITDA (TTM)
335.118
Gross margin (TTM)
44.84%
Net profit margin (TTM)
-10.45%
Operating margin (TTM)
5.82%
Revenue per employee (TTM)
kr 8,304,670
Management effectiveness
Return on assets (TTM)
2.06%
Return on equity (TTM)
-1.80%
Valuation
Price to revenue (TTM)
4.428
Price to book
65.21
Price to tangible book (TTM)
208.08
Price to free cash flow (TTM)
-197.109
Free cash flow yield (TTM)
-0.51%
Free cash flow per share (TTM)
-0.546
Growth
Revenue change (TTM)
9.60%
Earnings per share change (TTM)
-112.50%
3-year revenue growth (CAGR)
-7.68%
10-year revenue growth (CAGR)
7.57%
3-year earnings per share growth (CAGR)
33.20%
10-year earnings per share growth (CAGR)
38.52%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Aker BioMarine AS stock?
Aker BioMarine AS (AKBM) has a market cap of Nkr9.4B as of April 07, 2026.
What is the P/E ratio for Aker BioMarine AS stock?
The price to earnings (P/E) ratio for Aker BioMarine AS (AKBM) stock is 0 as of April 07, 2026.
Does Aker BioMarine AS stock pay dividends?
No, Aker BioMarine AS (AKBM) stock does not pay dividends to its shareholders as of April 07, 2026.
When is the next Aker BioMarine AS dividend payment date?
Aker BioMarine AS (AKBM) stock does not pay dividends to its shareholders.
What is the beta indicator for Aker BioMarine AS?
Aker BioMarine AS (AKBM) has a beta rating of 0.29. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.